When was Azra founded?

Azra was founded in 2022 and raised its 1st funding round 2 years after it was founded.

Where is Azra located?

Azra is headquartered in Franklin, United States.

Who is the current CEO of Azra?

Chris Cashwell of Azra. They have also founded 1 company.

How many employees does Azra have?

As of Jul 31, 2026, the latest employee count at Azra is 69.

Is Azra a funded company?

Azra is a funded company, having raised a total of $7.95M across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Dec 23, 2024.

When was the latest funding round of Azra?

Azra's latest funding was a $***** Series A round on Jun 06, 2025, with participation from 0 investor.

Where does Azra rank among its competitors?

Azra ranks 3rd amongst 47 active competitors, of which 11 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was NEOGAP, which secured $9.76M in Feb, 2026.

Who are the top competitors of Azra?

Azra's top competitors include Cyted, NEOGAP and Oncora. Among them, NEOGAP secured the most recent funding round in February, 2026.

Azra - 2026 Company Profile, Team, Funding & Competitors

Azra is a series A company based in Franklin (United States), founded in 2022 by Chris Cashwell. It operates as an AI and machine learning to automate oncology workflows. Azra has raised $7.95M in funding. The company has 47 active competitors, including 11 that are funded. Its top competitors include companies like Cyted, NEOGAP and Oncora.

Company Details

AI and machine learning to automate oncology workflows. It offers an AI powered oncology solution that automatically identifies, classifies, and abstracts cancer diagnoses and incidental findings from pathology and radiology reports. It manages oncology operations clinically, financially, and operationally. The features include cancer patient identification, generate, and manage radiology reports, populate data, compliance management, and more.

Website: www.azra-ai.com
Social

Key Metrics

Founded Year

2022

Location

Franklin, United States

Stage

Series A

Total Funding

$7.95M in 2 rounds

Latest Funding Round

Series A, Jun 06, 2025, $*****

Investors

FCA Venture Partners & 1 more

Ranked

3^rd among 47 active competitors

Employee Count

69 as on Jul 31, 2026

Investment & Acquisitions

Thynk Health

Similar Companies

OpenEvidence & 2885 more

View Azra's full profile

Azra has raised a total funding of $7.95M over 2 rounds. Its first funding round was on Dec 23, 2024. Azra has 2 institutional investors.

Here is the list of recent funding rounds of Azra:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 06, 2025	9532122	Series A	4032489	7632508	2464945	6662180
Dec 23, 2024	3241731	Series A	3221904	2381334	1300790	1829455

Access funding benchmarks and valuations. Sign up today!

View details of Azra's funding rounds and investors

The founders of Azra is Chris Cashwell. Chris Cashwell is the CEO of Azra.

Here are the details of Azra's key team members:

Chris Cashwell: Founder & CEO of Azra.

View details of Azra's Founder profiles and Board Members

Azra's employee count trend

Azra has 69 employees as of Jul 26. Here is Azra's employee count trend over the years:

Uncover Azra's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Azra include Cyted, NEOGAP and Oncora. Here is the list of Top 10 competitors of Azra, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Cyted 2018, Cambridge (United Kingdom), Series B	Leader in non-endoscopic diagnostics for digestive health, enabling early disease detection and access to care for all	$50.4M	Advent Life Sciences, EQT & 3 others	57/100
2nd	NEOGAP 2016, Stockholm (Sweden), Series A	Developer of radiopharmaceuticals for the treatment of cancer	$10.2M	Okomera, EIC Fund & 4 others	55/100
3rd	Azra 2022, Franklin (United States), Series A	AI and machine learning to automate oncology workflows	$7.95M	FCA Venture Partners, Sopris Capital	52/100
4th	Oncora 2014, Philadelphia (United States), Seed	AI-based clinical data analysis and decision support tool for oncologists	$3.11M	dhaphilly.com, Dorm Room Fund & 4 others	44/100
5th	Stratipath Medical 2019, Stockholm (Sweden), Unfunded	Provider of AI-based software for cancer treatments	-	-	42/100
6th	AliveX 2019, Zurich (Switzerland), Seed	Provider of an AI-based diagnostic platform for oncology and autoimmune diseases	-	K2VC, 5Y Capital & 1 others	38/100
7th	Cambridge Cancer Genomics 2015, Cambridge (United Kingdom), Acqui-Hired	Developer of AI-based precision medicine tools for oncologists	$4.62M	AME Cloud Ventures, Romulus Capital & 13 others	36/100
8th	CADESS 2016, Uppsala (Sweden), Seed	AI based decision support solution for healthcare professionals	-	Almi Invest, Vinnova & 3 others	32/100
9th	PreView Medical 2020, Longmont (United States), Funding Raised	Provider of an AI-based optical diagnostic tool for cancer treatment	-	Kyto Technology & Life Science, SeedFolio ... & 1 others	29/100
10th	MRImath 1980, Birmingham (United States), Early Stage	Provider of AI-based platform to improve cancer diagnosis and care	$200K	Rowan University	28/100